002022 科華生物
按盤價 
5.990 -0.020 (-0.333%)
5.990 -0.020 (-0.333%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -7.162 | -17.033 | -5.207 | 22.366 | 24.251 |
| 總資產報酬率 ROA (%) | -4.469 | -10.638 | -2.995 | 12.318 | 13.152 |
| 投入資產回報率 ROIC (%) | -5.768 | -13.821 | -4.129 | 17.643 | 18.129 | 邊際利潤分析 |
| 銷售毛利率 (%) | 35.812 | 36.791 | 42.765 | 52.557 | 54.544 |
| 營業利潤率 (%) | -21.048 | -41.316 | -7.386 | 29.630 | 33.815 |
| 息稅前利潤/營業總收入 (%) | -20.218 | -40.533 | -7.122 | 28.480 | 34.655 |
| 淨利潤/營業總收入 (%) | -21.307 | -41.533 | -7.289 | 24.853 | 27.889 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 80.980 | 48.308 | 57.831 | 105.581 | 98.313 |
| 價值變動淨收益/利潤總額(%) | -0.425 | -1.470 | -13.151 | 0.189 | -0.120 |
| 營業外收支淨額/利潤總額(%) | 0.406 | 1.092 | 3.384 | -0.001 | -0.250 | 償債能力分析 |
| 流動比率 (X) | 2.208 | 3.460 | 4.780 | 3.139 | 4.837 |
| 速動比率 (X) | 1.531 | 2.392 | 3.700 | 2.523 | 4.004 |
| 資產負債率 (%) | 27.532 | 23.944 | 26.786 | 33.637 | 26.224 |
| 帶息債務/全部投入資本 (%) | 19.289 | 13.214 | 17.698 | 18.078 | 19.024 |
| 股東權益/帶息債務 (%) | 402.469 | 631.681 | 448.473 | 438.286 | 412.404 |
| 股東權益/負債合計 (%) | 220.853 | 267.185 | 228.795 | 162.327 | 212.308 |
| 利息保障倍數 (X) | -22.086 | -32.726 | -13.635 | -24.765 | 37.518 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 183.220 | 201.932 | 178.210 | 58.719 | 66.215 |
| 存貨周轉天數 (天) | 301.484 | 299.571 | 290.347 | 113.936 | 129.263 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 17/03/2026 14:58 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
